The Response to Atropine Drops (RAD) Study

• Status: Not yet recruiting
• Trial end date: 2023-03-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to examine the comfort of giving low concentration atropine eye drops.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ohio State University
• Treatments: Atropine

Criteria

Inclusion Criteria:

• 18 years and older

Exclusion Criteria:

• None